Abstract 3784: Activity of the novel KIF18A inhibitor, ATX-295, is enriched in whole genome doubled ovarian cancer pre-clinical models
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Maureen M. Lynes, Sanjoy Kahn, Laura Ghisolfi, Jennifer Dobrodziej, Taylor Hotz, Dong-Hwan Kim, Brian A. Sparling, Hyelee Lee, Mary-Margaret Zablocki, Deepali Gotur, Livia Shehaj, Shane M. Buker, Matthew G. Rees, Melissa M. Ronan, Jennifer A. Roth, P Ann Boriack-Sjodin, Kenneth W. Duncan, Stephen J. Blakemore, Stuart Ince, Robert A. Copeland, Jason A. Sager, Serena J. Silver
Institutions: Accent Therapeutics (United States), Broad Institute
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409634828